AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic ...

Retrieved on: 2021-07-21 09:45:00

Tags for this article:

Click the tags to see associated articles and topics

AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic .... View article details on hiswai:

Excerpt

Venclexta is being developed by AbbVie Inc (NYSE: ABBV) and Roche Holdings AG (OTC: RHHBY). The Breakthrough status is intended to expedite ...

Article found on: www.benzinga.com